December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Johnson & Johnson

< Previous 1 2 3 4 5 Next >
News headline image
Johnson & Johnson Announces Pivotal Clinical Study Results for a New Soft-Tissue Surgical Robotic System
From Johnson & Johnson
Via Business Wire
Tickers JNJ
News headline image
Johnson & Johnson Appoints Ryan Koors as Vice President, Investor Relations
From Johnson & Johnson
Via Business Wire
Tickers JNJ
News headline image
Johnson & Johnson to Participate in the Bernstein’s 42nd Annual Strategic Decisions Conference
From Johnson & Johnson
Via Business Wire
Tickers JNJ
News headline image
Johnson & Johnson to Participate in the 2026 RBC Capital Markets Global Healthcare Conference
From Johnson & Johnson
Via Business Wire
Tickers JNJ
News headline image
Johnson & Johnson Showcases CARTO-Powered Innovation, Including Debut of CARTOSOUND SONATA, to Advance Arrhythmia Care at HRS 2026
From Johnson & Johnson
Via Business Wire
Tickers JNJ
News headline image
Johnson & Johnson to Participate in the Bank of America 2026 Healthcare Conference
From Johnson & Johnson
Via Business Wire
Tickers JNJ
News headline image
Johnson & Johnson Announces 64th Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 3.1%
From Johnson & Johnson
Via Business Wire
Tickers JNJ
News headline image
Johnson & Johnson reports Q1 2026 results, raises 2026 outlook
From Johnson & Johnson
Via Business Wire
Tickers JNJ
News headline image
Johnson & Johnson Showcases New Clinical Data for TECNIS PureSee IOL at ASCRS 2026 Demonstrating Excellent Contrast Sensitivity and Extended Range of Vision
From Johnson & Johnson
Via Business Wire
Tickers JNJ
News headline image
Johnson & Johnson Advances Pulsed Field Ablation Portfolio with the Launch of VARIPULSE Pro in Europe
From Johnson & Johnson
Via Business Wire
Tickers JNJ
News headline image
Johnson & Johnson Announces FDA Approval of TECNIS PureSee Intraocular Lens, a Breakthrough Solution for U.S. Cataract Patients
From Johnson & Johnson
Via Business Wire
Tickers JNJ
News headline image
Johnson & Johnson to Host Investor Conference Call on First-Quarter Results
From Johnson & Johnson
Via Business Wire
Tickers JNJ
News headline image
Johnson & Johnson Expands U.S. Footprint with more than $1 Billion Investment in Next Generation Cell Therapy Manufacturing Facility in Pennsylvania
From Johnson & Johnson
Via Business Wire
Tickers JNJ
News headline image
Johnson & Johnson to Participate in the Barclays 28th Annual Global Healthcare Conference
From Johnson & Johnson
Via Business Wire
Tickers JNJ
News headline image
Johnson & Johnson Presents Early Outcomes from the OMNY-AF Pilot Study at 2026 AF Symposium
From Johnson & Johnson
Via Business Wire
Tickers JNJ
News headline image
Johnson & Johnson to Participate in the TD Cowen 46th Annual Health Care Conference
From Johnson & Johnson
Via Business Wire
Tickers JNJ
News headline image
Johnson & Johnson Marks $100 Million of MedTech Products Donated Since 2020 to Help People Live, See and Smile
From Johnson & Johnson
Via Business Wire
Tickers JNJ
News headline image
Johnson & Johnson reports Q4 and Full-Year 2025 results
From Johnson & Johnson
Via Business Wire
Tickers JNJ
News headline image
Johnson & Johnson Reaches Agreement with U.S. Government to Improve Access to Medicines and Lower Costs for Millions of Americans; Delivers on U.S. Manufacturing and Innovation Investments
From Johnson & Johnson
Via Business Wire
Tickers JNJ
News headline image
Johnson & Johnson Submits OTTAVA™ Robotic Surgical System to the U.S. Food and Drug Administration
From Johnson & Johnson
Via Business Wire
Tickers JNJ
News headline image
Johnson & Johnson Announces Quarterly Dividend for First Quarter 2026
From Johnson & Johnson
Via Business Wire
Tickers JNJ
News headline image
Johnson & Johnson completes acquisition of Halda Therapeutics and its novel platform to revolutionize cancer treatment and enable next-generation oral therapies
From Johnson & Johnson
Via Business Wire
Tickers JNJ
News headline image
Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results
From Johnson & Johnson
Via Business Wire
Tickers JNJ
News headline image
Johnson & Johnson to Participate in the 44th Annual J.P. Morgan Healthcare Conference
From Johnson & Johnson
Via Business Wire
Tickers JNJ
News headline image
Johnson & Johnson Set to Revolutionize the Treatment of Cancer With the Acquisition of Halda Therapeutics
From Johnson & Johnson
Via Business Wire
Tickers JNJ
News headline image
Johnson & Johnson to Participate in the Citi’s 2025 Global Healthcare Conference
From Johnson & Johnson
Via Business Wire
Tickers JNJ
News headline image
Johnson & Johnson to Participate in the 7th Annual Wolfe Research Healthcare Conference
From Johnson & Johnson
Via Business Wire
Tickers JNJ
News headline image
Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2025
From Johnson & Johnson
Via Business Wire
Tickers JNJ
News headline image
Johnson & Johnson Announces Intent to Separate Its Orthopaedics Business
From Johnson & Johnson
Via Business Wire
Tickers JNJ
News headline image
Johnson & Johnson Reports Q3 2025 Results; Raises 2025 Sales Outlook
From Johnson & Johnson
Via Business Wire
Tickers JNJ
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.